What 4 Analyst Ratings Have To Say About Steris
Portfolio Pulse from Benzinga Insights
Steris (NYSE:STE) has been analyzed by 4 analysts, showing a shift towards a more bullish outlook with an average 12-month price target of $245.75, marking a 9.22% increase from the previous target. The company, a leader in sterilization services, shows solid revenue growth but lags in profitability and efficiency metrics compared to industry peers. Despite this, its lower debt-to-equity ratio suggests a healthier balance sheet.
February 09, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Steris receives a more bullish outlook from analysts with a new average 12-month price target of $245.75, indicating a potential upside. Despite challenges in profitability and efficiency, its leadership in sterilization services and solid revenue growth are positive indicators.
The increase in the average price target to $245.75 by analysts suggests a bullish sentiment towards Steris, likely due to its solid revenue growth and strong position in the sterilization services market. Despite some challenges in profitability and efficiency metrics, the company's lower debt-to-equity ratio indicates a healthier balance sheet, which could be appealing to investors. The overall positive outlook from analysts, combined with the company's market position and financial health, supports a likely short-term positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100